| 1 |
Vandoni M, Giuriato M, Pirazzi A, et al. Motor skills and executive functions in pediatric patients with down syndrome: a challenge for tailoring physical activity interventions[J]. Pediatr Rep, 2023, 15(4): 691-706.
|
| 2 |
Aprigio J, de Castro CML, Lima MAC, et al. Mothers of children with down syndrome: a clinical and epidemiological study[J]. J Community Genet, 2022, 14(2):189-195.
|
| 3 |
Mai CT, Isenburg JL, Canfield MA, et al. National population-based estimates for major birth defects, 2010-2014[J]. Birth Defects Res, 2019, 111(18):1420-1435.
|
| 4 |
Hamadelseed O, Chan MKS, Wong MBF, et al. Distinct neuroanatomical and neuropsychological features of down syndrome compared to related neurodevelopmental disorders: a systematic review[J]. Front Neurosci, 2023, 17:1225228.
|
| 5 |
Fortea J, Zaman SH, Hartley S, et al. Alzheimer's disease associated with Down syndrome: a genetic form of dementia[J]. Lancet Neurol, 2021, 20(11):930-942.
|
| 6 |
Fortea J, Vilaplana E, Carmona-Iragui M, et al. Clinical and biomarker changes of Alzheimer's disease in adults with down syndrome: a cross-sectional study[J]. Lancet, 2020, 395(10242):1988-1997.
|
| 7 |
Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research[J]. Nat Rev Neurol, 2019, 15(3):135-147.
|
| 8 |
Muza PM, Bush D, Pérez-González M, et al. Cognitive impairments in a down syndrome model with abnormal hippocampal and prefrontal dynamics and cytoarchitecture[J]. iScience, 2023, 26(2):106073.
|
| 9 |
Schill EM, Wright CM, Jamil A, et al. Down syndrome mouse models have an abnormal enteric nervous system[J]. JCI Insight, 2019, 5(11): e124510.
|
| 10 |
Cotta GC, Teixeira Dos Santos RC, Costa GMJ, et al. Reporter alleles in hipscs: visual cues on development and disease[J]. Int J Mol Sci, 2024, 25(20):11009.
|
| 11 |
Wang AYL, Aviña AE, Liu YY, et al. Pluripotent stem cells: recent advances and emerging trends[J]. Biomedicines, 2025, 13(4):765.
|
| 12 |
Fiacco E, Landi S, Zasso J, et al. Optimized and scalable precoating-free reprogramming of human peripheral blood mononuclear cells into iPSCs[J]. Curr Protoc, 2024, 4(1):e979.
|
| 13 |
Chen W, Wang C, Yang ZX, et al. Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors[J]. Commun Biol, 2023, 6(1):393.
|
| 14 |
Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells[J]. Cell, 2008, 134(5):877-886.
|
| 15 |
Laan L, Klar J, Sobol M, et al. DNA methylation changes in down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors[J]. Clin Epigenetics, 2020, 12(1):9.
|
| 16 |
Li Z, Klein JA, Rampam S, et al. Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome[J]. Front Neurosci, 2022, 16:932384.
|
| 17 |
Li J, Yin L, Wang C, et al. Generation of a homozygous ABCA7 knockout cell line (AHMUCNi002-A) in human iPSCs using CRISPR/Cas9[J]. Stem Cell Res, 2025, 85:103700.
|
| 18 |
Stern S, Segal M, Moses E. Involvement of potassium and cation channels in hippocampal abnormalities of embryonic ts65dn and tc1 trisomic mice[J]. EBioMedicine, 2015, 2(9):1048-1062.
|
| 19 |
Tang XY, Xu L, Wang J, et al. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome[J]. J Clin Invest, 2021, 131(12):e135763.
|
| 20 |
Huo HQ, Qu ZY, Yuan F, et al. Modeling down syndrome with patient ipscs reveals cellular and migration deficits of gabaergic neurons[J]. Stem Cell Reports, 2018, 10(4):1251-1266.
|
| 21 |
Rastogi M, Bartolucci M, Nanni M, et al. Integrative multi-omic analysis reveals conserved cell-projection deficits in human down brains[J]. Neuron, 2024, 112(15):2503-2523.e10.
|
| 22 |
Rachidi M, Lopes C. Mental retardation in down syndrome: From gene dosage imbalance to molecular and cellular mechanisms[J]. Neurosci Res, 2007, 59(4):349-369.
|
| 23 |
Head E, Lott IT, Wilcock DM, et al. Aging in down syndrome and the development of alzheimer's disease neuropathology[J]. Curr Alzheimer Res, 2016, 13(1):18-29.
|
| 24 |
Ochalek A, Mihalik B, Avci HX, et al. Neurons derived from sporadic alzheimer's disease ipscs reveal elevated tau hyperphosphorylation, increased amyloid levels, and gsk3b activation[J]. Alzheimers Res Ther, 2017, 9(1):90.
|